Talk:Chromosomal deletion syndrome
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||
|
Wiki Education Foundation-supported course assignment
editThis article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Ccoatsworth.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 19:04, 17 January 2022 (UTC)
Wiki Education Foundation-supported course assignment
editThis article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Nicolef004.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 19:04, 17 January 2022 (UTC)
This article is being expanded by Ccoatsworth as part of the course Biology 3595A: Advanced Genetics at The University of Western Ontario.Ccoatsworth (talk) 21:47, 15 October 2015 (UTC)
Expansion plans for Chromosomal deletion syndrome
editChromosomal deletion syndromes result from deletion of segments of chromosomes. Deletion in excess of 2% of original DNA mass usually result in death/abortion of Zygote. Smaller deletions result in Microdeletion syndrome, which are detected using fluorescence in situ hybridization (FISH). Large-scale deletions (>5 Mb) not resulting in death tend to result in Chromosomal deletion syndromes. Deletions of this magnitude are visible using karyotyping techniques.
Expand on the opening summary.
- larger deletion --> specific range of deletion sizes
- how it's done/detected/mapped
- type of equipment used (how powerful the microscopes need to be)
- when first defined
Detection and analysis
- what defines a deletion
- how is it detected
- limitations of detection
Location/structure of deletions
- brief summary of karyotyping (Karyotype)
- how comparisons are done to distinguish differences (deletions)
Mechanism/rate of deletions
Biological effects/consequences of chromosomal deletion syndrome
- gene/protein loss
- gene regulation
- compensation?
- disease
- Talk of specific examples:
[Some examples and facts related]
1p36 deletion syndrome: Affects 1 in 5-10,000 live births. — Preceding unsigned comment added by 67.234.22.121 (talk) 02:48, 20 June 2018 (UTC)
4p deletions
- The chromosomal basis of WHS consists of a deletion of the most terminal portion of the short arm of chromosome 4. The deleted segment of reported individuals represent about one half of the p arm, occurring distal to the bands 4p15.1-p15.2.
- Many reports are particularly striking in the appearance of the craniofacial structure (prominent forehead, hypertelorism, the wide bridge of the nose continuing to the forehead) which has led to the descriptive term “Greek warrior helmet appearance”.
- The proximal boundary of the WHSCR was defined by a 1.9 megabase terminal deletion of 4p16.3 that includes the proposed candidate genes LEMT1 and WHSC1. This was identified by two individuals that exhibited all 4 components of the core WHS phenotype, which allowed scientists to trace the loci of the deleted genes.
- There is wide evidence that the WHS core phenotype (growth delay, intellectual disability, seizures, and distinctive craniofacial features) is due to haploinsufficiency of several closely linked genes as opposed to a single gene. Related genes that impact variation include:
- WHSC2 (also known as NELF-A) is involved in multiple aspects of mRNA processing and the cell cycle
- SLBP, a gene encoding Stem Loop Binding Protein, resides telomeric to WHSC2, and plays a crucial role in regulating histone synthesis and availability during S phase
- LETM1 has initially been proposed as a candidate gene for seizures; it functions in ion exchange with potential roles in cell signaling and energy production.
- FGFRL1, encoding a putative fibroblast growth factor decoy receptor, has been implicated in the craniofacial phenotype and potentially other skeletal features, and short stature of WHS
- CPLX1 has lately been suggested as a potential candidate gene for epilepsy in WHS
- PIGG gene (Phosphotidilinositol glycan anchor biosynthesis, class G), involved in the biogenesis of GPI anchor proteins, has recently been implicated in the occurrence of seizures
- WHSC1 spans a 90-kb genomic region, two-thirds of which maps in the telomeric end of the WHCR; WHSC1 may play a significant role in normal development. Its deletion likely contributes to the WHS phenotype. However, variation in severity and phenotype of WHS suggests possible roles for genes that lie proximally and distally to the WHSCR
5p deletions
- With an incidence of 1 in 15,000 to 1 in 50,000 live births, it is suggested to be one of the most common contiguous gene deletion disorders.
- 5p deletions, whether terminal or interstitial, occur at different breakpoints; the variability seen among individuals may be attributed to the differences in their genotypes.
- Individuals that make up the population of those affected by 5p deletions comprise the 5p Minus Society, an online family support group in the United States
- 5p deletions are most commonly de novo occurrences, which are paternal in origin in 80–90% of cases, possibly arising from chromosome breakage during gamete formation in males
- There is no specific correlation found between size of deletion and severity of clinical features because the results vary so widely
- Some examples of the possible dysmorphic features include: downslanting palpebral fissures, broad nasal bridge,microcephaly, low-set ears, preauricular tags, round facies, short neck, micrognathia, and dental malocclusionhypertelorism, epicanthal folds, downturned corners of the mouthNicolef004 (talk) 05:10, 4 November 2015 (UTC)
Listed references will also be used to fill in other sections.
References
edit- ^ Cohen, Eyal; Chow, Eva W. C.; Weksberg, Rosanna; Bassett, Anne S. (1999-10-08). "Phenotype of Adults With the 22q11 Deletion Syndrome: A Review". American Journal of Medical Genetics. 86 (4): 359–365. ISSN 0148-7299. PMC 3276590. PMID 10494092.
- ^ Bassett, Anne S; Chow, Eva W.C. "22q11 deletion syndrome: a genetic subtype of schizophrenia". Biological Psychiatry. 46 (7): 882–891. doi:10.1016/s0006-3223(99)00114-6.
- ^ Swillen, A.; Vogels, A.; Devriendt, K.; Fryns, J. P. (2000-06-01). "Chromosome 22q11 deletion syndrome: Update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications". American Journal of Medical Genetics. 97 (2): 128–135. doi:10.1002/1096-8628(200022)97:23.0.CO;2-Z. ISSN 1096-8628.
- ^ Thomas, J. A.; Graham, J. M. "Chromosome 22q1l Deletion Syndrome: An Update and Review for the Primary Pediatrician". Clinical Pediatrics. 36 (5): 253–266. doi:10.1177/000992289703600502.
- ^ Clayton-Smith, J.; Laan, L. (2003-02-01). "Angelman syndrome: a review of the clinical and genetic aspects". Journal of Medical Genetics. 40 (2): 87–95. doi:10.1136/jmg.40.2.87. ISSN 1468-6244. PMC 1735357. PMID 12566516.
- ^ Butler, Merlin G. (1990-03-01). "Prader-Willi syndrome: Current understanding of cause and diagnosis". American Journal of Medical Genetics. 35 (3): 319–332. doi:10.1002/ajmg.1320350306. ISSN 1096-8628.